Rajnikanth Ravula, MD | |
3800 S Alma School Rd, Suite 112, Chandler, AZ 85248-4499 | |
(602) 900-9466 | |
(800) 230-9466 |
Full Name | Rajnikanth Ravula |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 24 Years |
Location | 3800 S Alma School Rd, Chandler, Arizona |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306028303 | NPI | - | NPPES |
352910 | Medicaid | AZ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 81689 (Arizona) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Firsthealth Home Care | West end, NC | Home health agency |
Firsthealth Moore Regional Hospital | Pinehurst, NC | Hospital |
St. Joseph's Hospital And Medical Center | Phoenix, AZ | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Zion Medical Group Pllc | 1355566464 | 39 |
Fhpg Llc | 9537481569 | 164 |
News Archive
"Speaking at a two-day development and investment conference for South Sudan in Washington, D.C., [Secretary of State] Hillary Clinton said the newly independent country had the potential to be 'one of Africa's breadbaskets'" and said the U.S. would work with private sector partners to invest in the nation's agriculture system, the Guardian reports.
Los Angeles Times: "Only months ago, supporters of the soda tax saw it as an idea whose hour was near. The sheer magnitude of the medical cost of obesity added urgency to the issue ... But opponents questioned any link between sugary drinks and obesity, and expressed concern about a slippery slope of taxes on other products. Proponents, meanwhile, thought a tax that drove down consumption while raising money for health care seemed like a natural with Democrats controlling Congress."
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the U.S. Food & Drug Administration (FDA) has cleared the Company to proceed with the proposed Phase 2 trial of PrevOnco™, its proprietary cancer treatment for patients with advanced, unresectable hepatocellular carcinoma (HCC), or liver cancer. The FDA granted PrevOnco™ orphan drug status in August 2008, and in March 2010, NexMed filed its Investigational New Drug (IND) application for the product candidate.
ActiveCare, Inc., a biotelematic technology company that specializes in products and services that help seniors manage and control their health and wellbeing while reducing overall costs to the healthcare industry, announced a capital raise commitment and balance sheet restructuring.
› Verified 5 days ago
Entity Name | Sjhmc Physician Services |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1326098005 PECOS PAC ID: 4486646197 Enrollment ID: O20040401001189 |
News Archive
"Speaking at a two-day development and investment conference for South Sudan in Washington, D.C., [Secretary of State] Hillary Clinton said the newly independent country had the potential to be 'one of Africa's breadbaskets'" and said the U.S. would work with private sector partners to invest in the nation's agriculture system, the Guardian reports.
Los Angeles Times: "Only months ago, supporters of the soda tax saw it as an idea whose hour was near. The sheer magnitude of the medical cost of obesity added urgency to the issue ... But opponents questioned any link between sugary drinks and obesity, and expressed concern about a slippery slope of taxes on other products. Proponents, meanwhile, thought a tax that drove down consumption while raising money for health care seemed like a natural with Democrats controlling Congress."
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the U.S. Food & Drug Administration (FDA) has cleared the Company to proceed with the proposed Phase 2 trial of PrevOnco™, its proprietary cancer treatment for patients with advanced, unresectable hepatocellular carcinoma (HCC), or liver cancer. The FDA granted PrevOnco™ orphan drug status in August 2008, and in March 2010, NexMed filed its Investigational New Drug (IND) application for the product candidate.
ActiveCare, Inc., a biotelematic technology company that specializes in products and services that help seniors manage and control their health and wellbeing while reducing overall costs to the healthcare industry, announced a capital raise commitment and balance sheet restructuring.
› Verified 5 days ago
Entity Name | Zion Medical Group Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184049322 PECOS PAC ID: 1355566464 Enrollment ID: O20140703001618 |
News Archive
"Speaking at a two-day development and investment conference for South Sudan in Washington, D.C., [Secretary of State] Hillary Clinton said the newly independent country had the potential to be 'one of Africa's breadbaskets'" and said the U.S. would work with private sector partners to invest in the nation's agriculture system, the Guardian reports.
Los Angeles Times: "Only months ago, supporters of the soda tax saw it as an idea whose hour was near. The sheer magnitude of the medical cost of obesity added urgency to the issue ... But opponents questioned any link between sugary drinks and obesity, and expressed concern about a slippery slope of taxes on other products. Proponents, meanwhile, thought a tax that drove down consumption while raising money for health care seemed like a natural with Democrats controlling Congress."
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the U.S. Food & Drug Administration (FDA) has cleared the Company to proceed with the proposed Phase 2 trial of PrevOnco™, its proprietary cancer treatment for patients with advanced, unresectable hepatocellular carcinoma (HCC), or liver cancer. The FDA granted PrevOnco™ orphan drug status in August 2008, and in March 2010, NexMed filed its Investigational New Drug (IND) application for the product candidate.
ActiveCare, Inc., a biotelematic technology company that specializes in products and services that help seniors manage and control their health and wellbeing while reducing overall costs to the healthcare industry, announced a capital raise commitment and balance sheet restructuring.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Rajnikanth Ravula, MD 3800 S Alma School Rd, Suite 112, Chandler, AZ 85248-4499 Ph: (602) 900-9466 | Rajnikanth Ravula, MD 3800 S Alma School Rd, Suite 112, Chandler, AZ 85248-4499 Ph: (602) 900-9466 |
News Archive
"Speaking at a two-day development and investment conference for South Sudan in Washington, D.C., [Secretary of State] Hillary Clinton said the newly independent country had the potential to be 'one of Africa's breadbaskets'" and said the U.S. would work with private sector partners to invest in the nation's agriculture system, the Guardian reports.
Los Angeles Times: "Only months ago, supporters of the soda tax saw it as an idea whose hour was near. The sheer magnitude of the medical cost of obesity added urgency to the issue ... But opponents questioned any link between sugary drinks and obesity, and expressed concern about a slippery slope of taxes on other products. Proponents, meanwhile, thought a tax that drove down consumption while raising money for health care seemed like a natural with Democrats controlling Congress."
NexMed, Inc., a specialty CRO with a pipeline of products based on the NexACT® technology, today announced that the U.S. Food & Drug Administration (FDA) has cleared the Company to proceed with the proposed Phase 2 trial of PrevOnco™, its proprietary cancer treatment for patients with advanced, unresectable hepatocellular carcinoma (HCC), or liver cancer. The FDA granted PrevOnco™ orphan drug status in August 2008, and in March 2010, NexMed filed its Investigational New Drug (IND) application for the product candidate.
ActiveCare, Inc., a biotelematic technology company that specializes in products and services that help seniors manage and control their health and wellbeing while reducing overall costs to the healthcare industry, announced a capital raise commitment and balance sheet restructuring.
› Verified 5 days ago
Dr. Jaskanwal Singh Bisla, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1955 W Frye Rd, Chandler, AZ 85224 Phone: 480-428-5500 | |
Dr. Naga Nalini Tirumalasetty, MD,ECNU,FACE. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 908 W Chandler Blvd Ste 4, Chandler, AZ 85225 Phone: 480-269-6448 Fax: 779-204-2331 | |
Amer Al-khoudari, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 604 W Warner Rd Ste C1, Chandler, AZ 85225 Phone: 480-372-8200 Fax: 480-372-8222 | |
Bidya Lohani-sharma, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 845 E Warner Rd Ste 101, Chandler, AZ 85225 Phone: 480-786-5000 Fax: 480-786-5050 | |
Nisar Ahmed, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3115 S Price Rd, Chandler, AZ 85248 Phone: 480-926-0170 Fax: 480-452-0715 | |
Chuck Stephen Mangubat, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3115 S Price Rd, Chandler, AZ 85248 Phone: 480-926-0170 Fax: 480-452-0715 | |
Gita Jafari-raske, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3115 S Price Rd, Chandler, AZ 85248 Phone: 480-926-0170 |